Sulforaphane protects the heart from doxorubicin-induced toxicity.

[1]  L. Khan,et al.  Amelioration of doxorubicin‑induced cardiotoxicity by resveratrol. , 2014, Molecular medicine reports.

[2]  Mihail I Mitov,et al.  Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment. , 2014, Free radical biology & medicine.

[3]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[4]  S. Niture,et al.  Regulation of Nrf2-an update. , 2014, Free radical biology & medicine.

[5]  K. Davies,et al.  How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo. , 2014, Free radical biology & medicine.

[6]  P. Oliveira,et al.  Doxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy , 2014, Medicinal research reviews.

[7]  C. Piantadosi,et al.  Peroxisome Proliferator-activated Receptor γ Co-activator 1-α as a Critical Co-activator of the Murine Hepatic Oxidative Stress Response and Mitochondrial Biogenesis in Staphylococcus aureus Sepsis* , 2013, The Journal of Biological Chemistry.

[8]  V. Dolinsky,et al.  Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. , 2013, American journal of physiology. Endocrinology and metabolism.

[9]  H. Griffiths,et al.  Sulforaphane Restores Cellular Glutathione Levels and Reduces Chronic Periodontitis Neutrophil Hyperactivity In Vitro , 2013, PloS one.

[10]  M. Boerma,et al.  Protection from Oxidative and Electrophilic Stress in the Gsta4-null Mouse Heart , 2013, Cardiovascular Toxicology.

[11]  C. Lemaire,et al.  Mitochondrial dynamics in the adult cardiomyocytes: which roles for a highly specialized cell? , 2013, Front. Physiol..

[12]  L. Cai,et al.  Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. , 2013, Journal of molecular and cellular cardiology.

[13]  I. Rahman,et al.  Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease. , 2013, Current medicinal chemistry.

[14]  M. Štěrba,et al.  Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. , 2013, Antioxidants & redox signaling.

[15]  Y. Awasthi,et al.  Gsta4 Null Mouse Embryonic Fibroblasts Exhibit Enhanced Sensitivity to Oxidants: Role of 4-Hydroxynonenal in Oxidant Toxicity. , 2013, Open journal of apoptosis.

[16]  H. McLeod,et al.  Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity. , 2013, Pharmacogenomics.

[17]  Q. Ma.  Role of nrf2 in oxidative stress and toxicity. , 2013, Annual review of pharmacology and toxicology.

[18]  I. Makhoul,et al.  Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model , 2012, PloS one.

[19]  L. MacMillan-Crow,et al.  MitoQ Blunts Mitochondrial and Renal Damage during Cold Preservation of Porcine Kidneys , 2012, PloS one.

[20]  M. Štěrba,et al.  Chronic Anthracycline Cardiotoxicity: Molecular and Functional Analysis with Focus on Nuclear Factor Erythroid 2-Related Factor 2 and Mitochondrial Biogenesis Pathways , 2012, Journal of Pharmacology and Experimental Therapeutics.

[21]  P. Álvarez,et al.  Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. , 2012, Anti-cancer agents in medicinal chemistry.

[22]  Q. Ma,et al.  Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2 , 2012, Pharmacological Reviews.

[23]  S. Lipshultz,et al.  Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. , 2012, Future cardiology.

[24]  R. Roberts,et al.  Drug-Induced Oxidative Stress and Toxicity , 2012, Journal of toxicology.

[25]  Anindita Das,et al.  Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications. , 2012, Nitric oxide : biology and chemistry.

[26]  M. Chello,et al.  Anthracycline cardiotoxicity , 2012, Expert opinion on drug safety.

[27]  E. Farombi,et al.  4-Hydroxynonenal induces mitochondrial-mediated apoptosis and oxidative stress in SH-SY5Y human neuronal cells. , 2012, Basic & clinical pharmacology & toxicology.

[28]  J. Marshall,et al.  Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implications for cancer prevention , 2012, British Journal of Nutrition.

[29]  S. Lipsitz,et al.  Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A. Maksimenko,et al.  Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress , 2012, Heart international.

[31]  Christopher J. Davidson,et al.  Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium. , 2012, Free radical biology & medicine.

[32]  Petr Jarolim,et al.  How to Interpret Elevated Cardiac Troponin Levels , 2011, Circulation.

[33]  V. Dolinsky,et al.  Calorie restriction and resveratrol in cardiovascular health and disease. , 2011, Biochimica et biophysica acta.

[34]  P. Zimniak.  Relationship of electrophilic stress to aging. , 2011, Free radical biology & medicine.

[35]  B. Gao,et al.  Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. , 2011, Molecular aspects of medicine.

[36]  Tina Hernandez-Boussard,et al.  Doxorubicin pathways: pharmacodynamics and adverse effects , 2011, Pharmacogenetics and genomics.

[37]  Min Zhang,et al.  Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo , 2011, Free radical biology & medicine.

[38]  P. Oliveira,et al.  Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol. , 2011, Current pharmaceutical design.

[39]  R. Margreiter,et al.  Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. , 2011, Biochimica et biophysica acta.

[40]  G. Cairo,et al.  Retracted: Role of hypoxia‐inducible factors in the dexrazoxane‐mediated protection of cardiomyocytes from doxorubicin‐induced toxicity , 2011, British journal of pharmacology.

[41]  A. Mesecar,et al.  Modification of keap1 cysteine residues by sulforaphane. , 2011, Chemical research in toxicology.

[42]  J. Yasha Kresh,et al.  Intercellular and extracellular mechanotransduction in cardiac myocytes , 2011, Pflügers Archiv - European Journal of Physiology.

[43]  Eddie Reed,et al.  Modulation of Protein Phosphatase 2A Activity Alters Androgen-Independent Growth of Prostate Cancer Cells: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.

[44]  D. Hittel,et al.  Respirometric oxidative phosphorylation assessment in saponin-permeabilized cardiac fibers. , 2011, Journal of visualized experiments : JoVE.

[45]  C. Carlberg,et al.  Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism* , 2011, Journal of Biological Chemistry.

[46]  M. Suematsu,et al.  4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. , 2010, Journal of molecular and cellular cardiology.

[47]  Xiang Lu,et al.  Doxorubicin induces apoptosis in H9c2 cardiomyocytes: role of overexpressed eukaryotic translation initiation factor 5A. , 2010, Biological & pharmaceutical bulletin.

[48]  B. Rosenzweig,et al.  Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats , 2010, Cancer Chemotherapy and Pharmacology.

[49]  David J. Arenillas,et al.  Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis , 2010, Nucleic acids research.

[50]  R. Cole,et al.  Electrophilic tuning of the chemoprotective natural product sulforaphane , 2010, Proceedings of the National Academy of Sciences.

[51]  S. Lancel,et al.  Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart. , 2010, Toxicology and applied pharmacology.

[52]  H. Chae,et al.  Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels. , 2010, Pharmacological research.

[53]  S. Niture,et al.  Nrf2:inrf2 (keap1) Signaling in Oxidative Stress , 2022 .

[54]  I. Russo,et al.  Platelet dysfunction in central obesity. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[55]  P. Hrelia,et al.  Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential. , 2009, Journal of agricultural and food chemistry.

[56]  D. Butterfield,et al.  Mrp1 Localization and Function in Cardiac Mitochondria after Doxorubicin , 2009, Molecular Pharmacology.

[57]  S. Amin,et al.  Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. , 2009, Cancer research.

[58]  M. Carraway,et al.  Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1 , 2008, Circulation research.

[59]  Masayuki Yamamoto,et al.  The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical Compounds , 2008, Molecular and Cellular Biology.

[60]  M. Disatnik,et al.  Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart , 2008, Science.

[61]  Mark S Williams,et al.  Spatially distinct production of reactive oxygen species regulates platelet activation. , 2008, Free radical biology & medicine.

[62]  A. Nel,et al.  Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells. , 2008, The Journal of allergy and clinical immunology.

[63]  Y. Awasthi,et al.  Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. , 2008, Biochemistry.

[64]  D. Das,et al.  Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. , 2008, Journal of agricultural and food chemistry.

[65]  S. Yusuf,et al.  Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation , 2007, International journal of nanomedicine.

[66]  John F. Reichard,et al.  Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1 , 2007, Nucleic acids research.

[67]  G. Mann,et al.  Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia. , 2007, Sheng li xue bao : [Acta physiologica Sinica].

[68]  E. Siegel,et al.  Life span and stress resistance of Caenorhabditis elegans are differentially affected by glutathione transferases metabolizing 4-hydroxynon-2-enal , 2007, Mechanisms of Ageing and Development.

[69]  G. Aldini,et al.  Lipoxidation‐Derived Reactive Carbonyl Species as Potential Drug Targets in Preventing Protein Carbonylation and Related Cellular Dysfunction , 2006, ChemMedChem.

[70]  J. Zweier,et al.  Antioxidants and Phase 2 Enzymes in Cardiomyocytes: Chemical Inducibility and Chemoprotection Against Oxidant and Simulated Ischemia-Reperfusion Injury , 2006, Experimental biology and medicine.

[71]  J. Zweier,et al.  4-Hydroxy-2-nonenal upregulates endogenous antioxidants and phase 2 enzymes in rat H9c2 myocardiac cells: Protection against overt oxidative and electrophilic injury , 2006, Free radical research.

[72]  Donna D. Zhang.  Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.

[73]  D. Butterfield,et al.  Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: Insight into chemobrain , 2005, Free radical research.

[74]  D. S. St. Clair,et al.  Oxidative Damage Precedes Nitrative Damage in Adriamycin-Induced Cardiac Mitochondrial Injury , 2004, Toxicologic pathology.

[75]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[76]  Lingyun Wu,et al.  Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Y. Usson,et al.  Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion. , 2004, American journal of physiology. Heart and circulatory physiology.

[78]  S. Srivastava,et al.  Membrane Association of Glutathione S-Transferase mGSTA4-4, an Enzyme That Metabolizes Lipid Peroxidation Products* , 2002, The Journal of Biological Chemistry.

[79]  Sudhir V. Shah,et al.  Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. , 2001, Kidney international.

[80]  K. Teraoka,et al.  Progressive cardiac dysfunction in adriamycin‐induced cardiomyopathy rats , 2000, European journal of heart failure.

[81]  M. Hayakari,et al.  A 1-hour enzyme-linked immunosorbent assay for quantitation of acrolein- and hydroxynonenal-modified proteins by epitope-bound casein matrix method. , 1999, Analytical biochemistry.

[82]  D. Sawyer,et al.  Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. , 1999, Circulation research.

[83]  Taewon Lee,et al.  Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model. , 2013, Toxicology and applied pharmacology.

[84]  Tao Chen,et al.  Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. , 2013, Topics in current chemistry.

[85]  V. Klimberg,et al.  Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer. , 2011, Anticancer research.

[86]  A. Ascensão,et al.  Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats. , 2011, Clinical science.

[87]  Sharda P. Singh,et al.  Disruption of the mGsta4 gene increases life span of C57BL mice. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[88]  C. Man,et al.  Cloning, sequence identification, and tissue expression analysis of novel chicken NYGGF4 gene , 2010, Molecular and Cellular Biochemistry.

[89]  D. Butterfield,et al.  Increase in Mrp 1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C 57 BL / 6 mice , 2006 .